(Q43045866)

English

Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine

scientific article published in April 2010

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit